EUVIMEDEUVIMED entdecken
Crossref

β-Hydroxy Thioether-Derived Ionizable Lipids for Spleen-Tropic mRNA Delivery and In Vivo Chimeric Antigen Receptor T Cell Engineering

Qiang Guo, Yuxuan Zhang, Xujia Yang, Qiang Liu, Junlin Sun, Tianyu Luo, Yubo Wang, Zilin Meng, Zijian Pan, Shunhao Wang, Yiran Yang, Yirong Sun und 3 weitere

ACS Nano · 26.05.2026 · 20 (20) · 14602-14614

DOI: 10.1021/acsnano.6c00706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 14.05.2026. Verfasst von Qiang Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Institute of Biomedical Engineering, Qingdao University, Qingdao 266071 Shandong, China. Hauptthemen laut MEDLINE: Spleen, Lipids, RNA, Messenger, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The delivery of nucleic acids via lipid nanoparticles (LNPs) to generate chimeric antigen receptor (CAR) T cells in vivo represents a promising therapeutic strategy for a broad spectrum of diseases. Nevertheless, the low efficiency of in vivo gene delivery to T cells remains a major obstacle. In this study, we established a structurally diverse combinatorial library of ionizable lipids based on a β-hydroxy thioether scaffold. From this library, 300 distinct ionizable lipids were synthesized and systematically evaluated for their mRNA delivery efficacy using a luciferase reporter assay in both in vitro and in vivo settings. We identified 113-AA-C8C14 as a leading candidate, which demonstrated a tropism for spleen-specific mRNA delivery. The 113-AA-C8C14 LNPs achieved a 57-fold enhancement in mRNA expression in the spleen compared to a benchmark selective organ-targeting (SORT) LNP formulation. Furthermore, when loaded with mRNA encoding a CD19-specific CAR, the 113-AA-C8C14 LNPs generated 2.7 times more CAR T cells in vivo. This was accompanied by an enhanced T cell response, evidenced by a 2.9-fold and 3.7-fold increase in the secretion of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α), respectively. Consequently, this approach led to a 2.3-fold greater inhibition of tumor growth in a mouse model of pancreatic cancer. Our study demonstrates the potential of the 113-AA-C8C14 LNP for in vivo CAR T cell therapy in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpleenLipidsRNA, MessengerReceptors, Chimeric AntigenSulfidesT-LymphocytesGene Transfer TechniquesAnimalsMiceHumansNanoparticlesFemale

Stichwörter der Autor:innen

gene therapyin vivo CAR T cell therapylipid nanoparticlesmRNAsplenic tropism

Substanzen

LipidsRNA, MessengerReceptors, Chimeric AntigenSulfides

Autor:innen und Institutionen

  • College of Life Sciences, Institute of Biomedical Engineering, Qingdao University, Qingdao 266071 Shandong, China.
  • Beijing Life Science Academy, Beijing 102209, China.
  • New Cornerstone Science Laboratory, Department of Chemistry, Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing 100084, China.
  • School of Biomedical Engineering, Qilu Hospital, Shandong University, Jinan 250012, China.
  • Division of Life Sciences and Medicine, Center for BioAnalytical Chemistry, University of Science and Technology of China, Hefei 230026, China.
  • Center for BioAnalytical Chemistry, Hefei National Research Center for Physical Science at Microscale, University of Science and Technology of China, Hefei 230026, China.

ORCID-Profile: Ningqiang Gong, Jinghong Li

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China
  • New Cornerstone Investigator Program
  • Beijing Life Science Academy Initiative Scientific Research Program

Zitieren

APA

Guo, Q., Zhang, Y., Yang, X., Liu, Q., Sun, J., Luo, T., Wang, Y., Meng, Z., Pan, Z., Wang, S., Yang, Y., Sun, Y., Huang, X., Gong, N., & Li, J. (2026). β-Hydroxy Thioether-Derived Ionizable Lipids for Spleen-Tropic mRNA Delivery and In Vivo Chimeric Antigen Receptor T Cell Engineering. ACS Nano, 20(20), 14602-14614. https://doi.org/10.1021/acsnano.6c00706

Vancouver

Guo Q, Zhang Y, Yang X, Liu Q, Sun J, Luo T, et al. β-Hydroxy Thioether-Derived Ionizable Lipids for Spleen-Tropic mRNA Delivery and In Vivo Chimeric Antigen Receptor T Cell Engineering. ACS Nano. 2026;20(20):14602-14614. doi:10.1021/acsnano.6c00706

BibTeX
@article{Guo2026,
  author = {Guo, Qiang and Zhang, Yuxuan and Yang, Xujia and Liu, Qiang and Sun, Junlin and Luo, Tianyu and Wang, Yubo and Meng, Zilin and Pan, Zijian and Wang, Shunhao and Yang, Yiran and Sun, Yirong and Huang, Xuefeng and Gong, Ningqiang and Li, Jinghong},
  title = {β-Hydroxy Thioether-Derived Ionizable Lipids for Spleen-Tropic mRNA Delivery and In Vivo Chimeric Antigen Receptor T Cell Engineering},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {20},
  pages = {14602--14614},
  doi = {10.1021/acsnano.6c00706}
}
Kostenlos starten →